Omadacycline: a review of the clinical pharmacokinetics and pharmacodynamics
KA Rodvold, RM Burgos, X Tan, MP Pai - Clinical pharmacokinetics, 2020 - Springer
… to a successful drug development program and US Food and Drug Administration (FDA) …
provides a comprehensive summary of the clinical pharmacokinetic and pharmacodynamic …
provides a comprehensive summary of the clinical pharmacokinetic and pharmacodynamic …
A practical guide to secondary pharmacology in drug discovery
S Jenkinson, F Schmidt, LR Ribeiro… - … of Pharmacological and …, 2020 - Elsevier
… in pharmaceutical drug discovery to address unwanted pharmacological side effects of
drug … allows to exploit synergies for comprehensive safety assessment of drug candidates. …
drug … allows to exploit synergies for comprehensive safety assessment of drug candidates. …
Preclinical pharmacokinetic/pharmacodynamic studies and clinical trials in the drug development process of EMA-approved antibacterial agents: a review
A Jorda, M Zeitlinger - Clinical Pharmacokinetics, 2020 - Springer
… pharmacokinetic/pharmacodynamic studies in dosing optimization and decision making in
antimicrobial drug development. … a comprehensive review of the development process of all …
antimicrobial drug development. … a comprehensive review of the development process of all …
Machine learning approaches and their applications in drug discovery and design
S Priya, G Tripathi, DB Singh, P Jain… - … Biology & Drug Design, 2022 - Wiley Online Library
… drug discovery. Many physicochemical properties of drugs like toxicity, absorption, drug‐drug …
tremendous potential in the field of drug discovery. Techniques discussed in this review …
tremendous potential in the field of drug discovery. Techniques discussed in this review …
… of malignant tumors of the female reproductive system: A review of traditional Chinese medicinal uses, phytochemistry, pharmacokinetics, and pharmacodynamics
X Pan, Q Shen, C Zhang, X Zhang, Y Li… - Frontiers in …, 2023 - frontiersin.org
… and inform novel drug development for treating … integration effect for the identification of
more lead compounds that could be the foundation for the discovery of new anti-tumor drugs. …
more lead compounds that could be the foundation for the discovery of new anti-tumor drugs. …
Approaches to dose finding in neonates, illustrating the variability between neonatal drug development programs
JN Van den Anker, S McCune, P Annaert, GR Baer… - Pharmaceutics, 2020 - mdpi.com
… Drug dosing in neonates should be based on integrated knowledge concerning the disease
… neonate, and the pharmacokinetics (PK) and pharmacodynamics (PD) of a given drug. It is …
… neonate, and the pharmacokinetics (PK) and pharmacodynamics (PD) of a given drug. It is …
Adverse drug reactions of acetylcholinesterase inhibitors in older people living with dementia: a comprehensive literature review
S Ruangritchankul, P Chantharit… - … and Clinical Risk …, 2021 - Taylor & Francis
… in pharmacokinetics (PK), pharmacodynamics (PD) and pharmacogenetics (PGx), and
occurrence of drug … To date, comprehensive reviews in ADRs of AChEIs have so far been scarcely …
occurrence of drug … To date, comprehensive reviews in ADRs of AChEIs have so far been scarcely …
Phase 1 studies to define the safety, tolerability, and pharmacokinetic and pharmacodynamic profiles of the nonsteroidal mineralocorticoid receptor antagonist …
T Nakamura, A Kawaguchi - … in Drug Development, 2021 - Wiley Online Library
Apararenone is a long‐acting, nonsteroidal mineralocorticoid receptor antagonist (MRA). The
safety, tolerability, and pharmacokinetic (PK) and pharmacodynamic (PD) profiles of single…
safety, tolerability, and pharmacokinetic (PK) and pharmacodynamic (PD) profiles of single…
Druggability and drug-likeness concepts in drug design: are biomodelling and predictive tools having their say?
… discovery field. Herein, we present the different … in the drug discovery domain. We believe
that this report would serve as a comprehensive guide towards computational-oriented drug …
that this report would serve as a comprehensive guide towards computational-oriented drug …